Cancer Metabolism and Tumor Heterogeneity: Imaging Perspectives Using MR Imaging and Spectroscopy
暂无分享,去创建一个
[1] P. Reimer,et al. Contrast mechanisms in MR imaging , 1999, European Radiology.
[2] Paul Kinahan,et al. Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.
[3] A. Brodbelt,et al. Cellularity and apparent diffusion coefficient in oligodendroglial tumours characterized by genotype , 2010, Journal of Neuro-Oncology.
[4] M. McMahon,et al. Developing imidazoles as CEST MRI pH sensors. , 2016, Contrast media & molecular imaging.
[5] R. Gillies,et al. Quantitative imaging in cancer evolution and ecology. , 2013, Radiology.
[6] Jan Wolber,et al. Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy , 2007, Nature Medicine.
[7] Anthony Mancuso,et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.
[8] Edward A. Randtke,et al. Multislice CEST MRI improves the spatial assessment of tumor pH , 2017, Magnetic resonance in medicine.
[9] E. Gottlieb,et al. Targeting metabolic transformation for cancer therapy , 2010, Nature Reviews Cancer.
[10] H. Rugo. Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer , 2007 .
[11] A. Lane,et al. Ras transformation requires metabolic control by 6-phosphofructo-2-kinase , 2006, Oncogene.
[12] M. Essig,et al. Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. , 2001, International journal of radiation oncology, biology, physics.
[13] Robert Rohling,et al. MR elastography of prostate cancer: quantitative comparison with histopathology and repeatability of methods , 2014, NMR in biomedicine.
[14] Allison S. Cleary. Teamwork: The tumor cell edition , 2015, Science.
[15] F. Gallagher,et al. Hyperpolarized [1-13C]-Ascorbic and Dehydroascorbic Acid: Vitamin C as a Probe for Imaging Redox Status in Vivo , 2011, Journal of the American Chemical Society.
[16] Noam Nissan,et al. Can diffusion tensor anisotropy indices assist in breast cancer detection? , 2016, Journal of magnetic resonance imaging : JMRI.
[17] Shingo Matsumoto,et al. Simultaneous imaging of tumor oxygenation and microvascular permeability using Overhauser enhanced MRI , 2009, Proceedings of the National Academy of Sciences.
[18] P. Vaupel,et al. Tumor hypoxia and malignant progression. , 2009, Methods in enzymology.
[19] K. Painter,et al. Mathematical modelling of glioma growth: the use of Diffusion Tensor Imaging (DTI) data to predict the anisotropic pathways of cancer invasion. , 2013, Journal of theoretical biology.
[20] Claudio R. Santos,et al. SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth , 2008, Cell metabolism.
[21] A. Uluğ,et al. Diagnostic utility of DTI in prostate cancer. , 2011, European journal of radiology.
[22] Jinyuan Zhou,et al. Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging , 2008, Magnetic resonance in medicine.
[23] Ashish Jindal,et al. Comparison of kinetic models for analysis of pyruvate‐to‐lactate exchange by hyperpolarized 13C NMR , 2012, NMR in biomedicine.
[24] Franziska Hirschhaeuser,et al. Lactate: a metabolic key player in cancer. , 2011, Cancer research.
[25] Albert P. Chen,et al. Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. , 2008, Cancer research.
[26] Bernard Gallez,et al. How does blood oxygen level‐dependent (BOLD) contrast correlate with oxygen partial pressure (pO2) inside tumors? , 2002, Magnetic resonance in medicine.
[27] E. Haacke,et al. Susceptibility‐Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions , 2016, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[28] J. Winther,et al. Non-invasive In-cell Determination of Free Cytosolic [NAD+]/[NADH] Ratios Using Hyperpolarized Glucose Show Large Variations in Metabolic Phenotypes* , 2013, The Journal of Biological Chemistry.
[29] Kevin Camphausen,et al. Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] Carl-Fredrik Westin,et al. The link between diffusion MRI and tumor heterogeneity: Mapping cell eccentricity and density by diffusional variance decomposition (DIVIDE) , 2016, NeuroImage.
[31] M. Pagel,et al. Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI , 2014, Magnetic resonance in medicine.
[32] Meiyappan Solaiyappan,et al. Collagen fibers mediate MRI-detected water diffusion and anisotropy in breast cancers , 2016, Neoplasia.
[33] Amy C. Dwyer,et al. Models and methods for analyzing DCE-MRI: a review. , 2014, Medical physics.
[34] Donald S. Williams,et al. Perfusion imaging , 1992, Magnetic resonance in medicine.
[35] P. Choyke,et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.
[36] M. Kransdorf,et al. Radiologic evaluation of soft-tissue masses: a current perspective. , 2000, AJR. American journal of roentgenology.
[37] John Kurhanewicz,et al. Multi-compound polarization by DNP allows simultaneous assessment of multiple enzymatic activities in vivo. , 2010, Journal of magnetic resonance.
[38] A. Manduca,et al. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. , 1995, Science.
[39] Ferdinand Schweser,et al. Quantitative Susceptibility Mapping Differentiates between Blood Depositions and Calcifications in Patients with Glioblastoma , 2013, PloS one.
[40] P. Friedl. Immunological techniques: Dynamic imaging of the immune system , 2004 .
[41] A. Gregory Sorensen,et al. Angiogenesis in brain tumours , 2007, Nature Reviews Neuroscience.
[42] P. Larson,et al. Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-13C]Pyruvate , 2013, Science Translational Medicine.
[43] M. Augsten. Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment , 2014, Front. Oncol..
[44] W J Niessen,et al. Heterogeneity in DCE-MRI parametric maps: a biomarker for treatment response? , 2011, Physics in medicine and biology.
[45] R. Gillies,et al. Janus-faced tumor microenvironment and redox. , 2014, Antioxidants & redox signaling.
[46] J. Folkman. Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.
[47] F. Cendes,et al. Texture analysis of medical images. , 2004, Clinical radiology.
[48] James B. Mitchell,et al. Overhauser enhanced magnetic resonance imaging for tumor oximetry: Coregistration of tumor anatomy and tissue oxygen concentration , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[49] J. Ardenkjær-Larsen,et al. Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[50] J. Helpern,et al. Diffusional kurtosis imaging: The quantification of non‐gaussian water diffusion by means of magnetic resonance imaging , 2005, Magnetic resonance in medicine.
[51] Olav Haraldseth,et al. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging , 2000, Magnetic resonance in medicine.
[52] Bernard Gallez,et al. Qualification of a Noninvasive Magnetic Resonance Imaging Biomarker to Assess Tumor Oxygenation , 2014, Clinical Cancer Research.
[53] Robert J Gillies,et al. Imaging pH and metastasis , 2011, NMR in biomedicine.
[54] Z. Bhujwalla,et al. Choline metabolism in malignant transformation , 2011, Nature Reviews Cancer.
[55] G. Semenza,et al. Uterine DCs are essential for pregnancy. , 2008, The Journal of clinical investigation.
[56] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[57] E. Terreno,et al. Probing treatment response of glutaminolytic prostate cancer cells to natural drugs with hyperpolarized [5‐13C]glutamine , 2015, Magnetic resonance in medicine.
[58] U. Motosugi,et al. Liver stiffness measured by magnetic resonance elastography as a risk factor for hepatocellular carcinoma: a preliminary case–control study , 2012, European Radiology.
[59] P. Lambin,et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.
[60] R. Kauppinen,et al. Tumour metabolomics in animal models of human cancer. , 2007, Journal of proteome research.
[61] J. Lagendijk,et al. Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[62] M. Dewey,et al. Fractal analysis in radiological and nuclear medicine perfusion imaging: a systematic review , 2013, European Radiology.
[63] Bal Sanghera,et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? , 2012, Insights into Imaging.
[64] Richard L Ehman,et al. Magnetic resonance elastography (MRE) in cancer: Technique, analysis, and applications. , 2015, Progress in nuclear magnetic resonance spectroscopy.
[65] Stephanie Alexander,et al. Cancer Invasion and the Microenvironment: Plasticity and Reciprocity , 2011, Cell.
[66] A. Jackson,et al. Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives. , 2008, The Lancet. Oncology.
[67] Jing Yan,et al. Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging , 2016, BMC Cancer.
[68] R. Lenkinski,et al. pH imaging of mouse kidneys in vivo using a frequency‐dependent paraCEST agent , 2016, Magnetic resonance in medicine.
[69] John Kurhanewicz,et al. Hyperpolarized 13C dehydroascorbate as an endogenous redox sensor for in vivo metabolic imaging , 2011, Proceedings of the National Academy of Sciences.
[70] Shingo Matsumoto,et al. Magnetic resonance imaging of tumor oxygenation and metabolic profile , 2013, Acta oncologica.
[71] M Fink,et al. Imaging anisotropic and viscous properties of breast tissue by magnetic resonance‐elastography , 2005, Magnetic resonance in medicine.
[72] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[73] A. Acharya,et al. Redox regulation in cancer , 2010, Oxidative medicine and cellular longevity.
[74] D. Le Bihan,et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.
[75] E. Rofstad,et al. Temporal heterogeneity in blood supply in human tumor xenografts. , 2008, Neoplasia.
[76] J. Settleman,et al. Recent advances in pathway-targeted cancer drug therapies emerging from cancer genome analysis. , 2012, Current opinion in genetics & development.
[77] J. Downward. Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.
[78] R. Jain,et al. 2H-nuclear magnetic resonance imaging of tumor blood flow: spatial and temporal heterogeneity in a tissue-isolated mammary adenocarcinoma. , 1992, Cancer research.
[79] P. Lambin,et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.
[80] Vladimir Ponomarev,et al. Molecular Imaging of Temporal Dynamics and Spatial Heterogeneity of Hypoxia-Inducible Factor-1 Signal Transduction Activity in Tumors in Living Mice , 2004, Cancer Research.
[81] R. Wu,et al. A method for accurate pH mapping with chemical exchange saturation transfer (CEST) MRI. , 2016, Contrast media & molecular imaging.
[82] Guoying Liu,et al. Expanding the use of magnetic resonance in the assessment of tumor response to therapy: workshop report. , 2005, Cancer research.
[83] G. Parker,et al. Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome , 2014, Clinical Cancer Research.
[84] James B. Mitchell,et al. The relationship between tissue oxygenation and redox status using magnetic resonance imaging , 2012, International journal of oncology.
[85] Ash A. Alizadeh,et al. Toward understanding and exploiting tumor heterogeneity , 2015, Nature Medicine.
[86] A. Alavi,et al. Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.
[87] Pascal Spincemaille,et al. Flow compensated quantitative susceptibility mapping for venous oxygenation imaging , 2014, Magnetic resonance in medicine.
[88] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[89] O. Feron,et al. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[90] Marc S Ramirez,et al. Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors. , 2015, Cancer research.
[91] P. Grigsby,et al. Intratumoral Metabolic Heterogeneity of Cervical Cancer , 2008, Clinical Cancer Research.
[92] E. Maher,et al. Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[93] M. Dewhirst. Relationships between Cycling Hypoxia, HIF-1, Angiogenesis and Oxidative Stress , 2009, Radiation research.
[94] C. Zimmer,et al. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. , 2003, Radiology.
[95] T. Hirai,et al. Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. , 2006, AJNR. American journal of neuroradiology.
[96] Himanshu Bhat,et al. Quantitative oxygenation venography from MRI phase , 2014, Magnetic resonance in medicine.
[97] M. V. Heiden,et al. Targeting cancer metabolism: a therapeutic window opens , 2011, Nature Reviews Drug Discovery.
[98] Shixiu Wu,et al. Single-Cell Sequencing for Precise Cancer Research: Progress and Prospects. , 2016, Cancer research.
[99] C. Dessy,et al. Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors. , 2012, Cancer research.
[100] D. Yablonskiy,et al. Quantitative BOLD: Mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: Default state , 2007, Magnetic resonance in medicine.
[101] P. Rich. The molecular machinery of Keilin's respiratory chain. , 2003, Biochemical Society transactions.
[102] M. Kanematsu,et al. Diffusion kurtosis imaging to assess response to treatment in hypervascular hepatocellular carcinoma. , 2015, AJR. American journal of roentgenology.
[103] R. Ehman,et al. Magnetic resonance elastography: A review , 2010, Clinical anatomy.
[104] F. Gallagher,et al. Magnetic resonance imaging with hyperpolarized [1,4-13C2]fumarate allows detection of early renal acute tubular necrosis , 2012, Proceedings of the National Academy of Sciences.
[105] R. Weinshilboum,et al. Metabolomics: a global biochemical approach to drug response and disease. , 2008, Annual review of pharmacology and toxicology.
[106] H. Halpern,et al. Towards Human Oxygen Images with Electron Paramagnetic Resonance Imaging. , 2016, Advances in experimental medicine and biology.
[107] Hans Knutsson,et al. Cluster failure: Why fMRI inferences for spatial extent have inflated false-positive rates , 2016, Proceedings of the National Academy of Sciences.
[108] N. Just,et al. Improving tumour heterogeneity MRI assessment with histograms , 2014, British Journal of Cancer.
[109] Ferdia A Gallagher,et al. A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment. , 2009, Neoplasia.
[110] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[111] Miklós Espák,et al. Cluster analysis of quantitative parametric maps from DCE-MRI: application in evaluating heterogeneity of tumor response to antiangiogenic treatment. , 2015, Magnetic resonance imaging.
[112] H. Lincet,et al. A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells. , 2012, Biochimica et biophysica acta.
[113] Geoff J M Parker,et al. Organ‐specific effects of oxygen and carbogen gas inhalation on tissue longitudinal relaxation times , 2007, Magnetic resonance in medicine.
[114] E. Melhem,et al. Diffusion kurtosis imaging: an emerging technique for evaluating the microstructural environment of the brain. , 2014, AJR. American journal of roentgenology.
[115] A Gregory Sorensen,et al. Diffusion and diffusion tensor imaging in brain cancer. , 2011, Seminars in radiation oncology.
[116] N. McGranahan,et al. The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.
[117] E. Maher,et al. Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting. , 2017, Journal of neurosurgery.
[118] Wenzhen Zhu,et al. Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation , 2015, Oncotarget.
[119] S. Patra,et al. A short review on creatine–creatine kinase system in relation to cancer and some experimental results on creatine as adjuvant in cancer therapy , 2011, Amino Acids.
[120] Giovanna Rizzo,et al. Texture analysis of medical images for radiotherapy applications. , 2017, The British journal of radiology.
[121] R. Franklin,et al. ‘Why do tumour cells glycolyse?’: From glycolysis through citrate to lipogenesis , 2005, Molecular and Cellular Biochemistry.
[122] Thomas E Yankeelov,et al. MR Imaging Biomarkers in Oncology Clinical Trials. , 2016, Magnetic resonance imaging clinics of North America.
[123] R. Damadian. Tumor Detection by Nuclear Magnetic Resonance , 1971, Science.
[124] A. Haase,et al. Quantified pH imaging with hyperpolarized 13C‐bicarbonate , 2015, Magnetic resonance in medicine.
[125] Mikko I. Kettunen,et al. Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose , 2013, Nature Medicine.
[126] K. Zaner,et al. Human tumors detected by nuclear magnetic resonance. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[127] A. McCullough,et al. Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing , 2013 .
[128] R. Jain. Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[129] Chi V Dang,et al. Cancer's molecular sweet tooth and the Warburg effect. , 2006, Cancer research.
[130] Jing Zhang,et al. The Histogram Analysis of Diffusion-Weighted Intravoxel Incoherent Motion (IVIM) Imaging for Differentiating the Gleason grade of Prostate Cancer , 2015, European Radiology.
[131] Kunwei Shen,et al. Breast Cancer: Diffusion Kurtosis MR Imaging-Diagnostic Accuracy and Correlation with Clinical-Pathologic Factors. , 2015, Radiology.
[132] Quantitative analysis of whole‐tumor Gd enhancement histograms predicts malignant transformation in low‐grade gliomas , 2007, Journal of magnetic resonance imaging : JMRI.
[133] F. Gallagher,et al. Detection of tumor glutamate metabolism in vivo using 13C magnetic resonance spectroscopy and hyperpolarized [1‐13C]glutamate , 2011, Magnetic resonance in medicine.
[134] Simon V. Avery,et al. Microbial cell individuality and the underlying sources of heterogeneity , 2006, Nature Reviews Microbiology.
[135] Bejoy Thomas,et al. Principles, techniques, and applications of T2*-based MR imaging and its special applications. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.
[136] Michael P. Lisanti,et al. Mitochondrial dysfunction in breast cancer cells prevents tumor growth , 2013, Cell cycle.
[137] Heinz-Otto Peitgen,et al. Diffusion tensor imaging in primary brain tumors: Reproducible quantitative analysis of corpus callosum infiltration and contralateral involvement using a probabilistic mixture model , 2006, NeuroImage.
[138] P. López-Larrubia,et al. Imaging tumor hypoxia by magnetic resonance methods , 2011, NMR in Biomedicine.
[139] P. Barker,et al. N‐Acetyl Aspartate—A Neuronal Marker? , 2001, Annals of neurology.
[140] James L Tatum,et al. Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy , 2006, International journal of radiation biology.
[141] Geoff J M Parker,et al. Imaging Tumor Vascular Heterogeneity and Angiogenesis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging , 2007, Clinical Cancer Research.
[142] Bram Stieltjes,et al. Prediction of treatment response in head and neck carcinomas using IVIM-DWI: Evaluation of lymph node metastasis. , 2014, European journal of radiology.
[143] Philippe Lambin,et al. PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[144] Robert J Gillies,et al. Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478. , 2005, Neoplasia.
[145] Axel Haase,et al. Imaging of pH in vivo using hyperpolarized 13C-labelled zymonic acid , 2017, Nature Communications.
[146] W. Niessen,et al. Quantification of Heterogeneity as a Biomarker in Tumor Imaging: A Systematic Review , 2014, PloS one.
[147] C. Helms,et al. Lipomas, lipoma variants, and well-differentiated liposarcomas (atypical lipomas): results of MRI evaluations of 126 consecutive fatty masses. , 2004, AJR. American journal of roentgenology.
[148] N. deSouza,et al. Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images. , 2013, AJR. American journal of roentgenology.
[149] H. Kauczor,et al. IVIM-diffusion-MRI for the differentiation of solid benign and malign hypervascular liver lesions-Evaluation with two different MR scanners. , 2016, European journal of radiology.
[150] Michele Guindani,et al. Role of Increased n-acetylaspartate Levels in Cancer. , 2016, Journal of the National Cancer Institute.
[151] Julien Verrax,et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.
[152] R. Deberardinis,et al. Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker , 2015, Cancer Prevention Research.
[153] Jun Liu,et al. Preliminary Study of MR Diffusion Tensor Imaging of the Liver for the Diagnosis of Hepatocellular Carcinoma , 2015, PloS one.
[154] T. Jang,et al. Hyperpolarized 13C‐lactate to 13C‐bicarbonate ratio as a biomarker for monitoring the acute response of anti‐vascular endothelial growth factor (anti‐VEGF) treatment , 2016, NMR in biomedicine.
[155] Pradeep S Rajendran,et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors , 2011, Nature Biotechnology.
[156] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[157] G. Johnson,et al. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer. , 2012, Radiology.
[158] H. Vargas,et al. Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses. , 2016, Radiology.
[159] Thomas Christen,et al. Evaluation of a quantitative blood oxygenation level‐dependent (qBOLD) approach to map local blood oxygen saturation , 2010, NMR in biomedicine.
[160] P. Lambin,et al. Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion , 2015, European Journal of Nuclear Medicine and Molecular Imaging.
[161] Current measures of metabolic heterogeneity within cervical cancer do not predict disease outcome , 2011, Radiation oncology.
[162] A. Jackson,et al. Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies , 2012, Nature Reviews Clinical Oncology.
[163] Fu-Nien Wang,et al. Analysis of parametric histogram from dynamic contrast‐enhanced MRI: application in evaluating brain tumor response to radiotherapy , 2013, NMR in biomedicine.
[164] I. Sack,et al. High Resolution Imaging of Viscoelastic Properties of Intracranial Tumours by Multi-Frequency Magnetic Resonance Elastography , 2015, Clinical Neuroradiology.
[165] Geoff J M Parker,et al. Preliminary study of oxygen-enhanced longitudinal relaxation in MRI: a potential novel biomarker of oxygenation changes in solid tumors. , 2009, International journal of radiation oncology, biology, physics.
[166] P. Barker,et al. Imaging of brain tumors: MR spectroscopy and metabolic imaging. , 2010, Neuroimaging clinics of North America.
[167] R A Jungmann,et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[168] A. Berns,et al. A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer. , 2011, Cancer cell.
[169] J. Pouysségur,et al. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H+ symporters , 2015, Journal of Molecular Medicine.
[170] Hanlee P. Ji,et al. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity , 2015, Nature Medicine.
[171] Freya Q. Schafer,et al. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. , 2001, Free radical biology & medicine.
[172] A. Manduca,et al. MR elastography of breast cancer: preliminary results. , 2002, AJR. American journal of roentgenology.
[173] Robert J. Gillies,et al. A microenvironmental model of carcinogenesis , 2008, Nature Reviews Cancer.
[174] Matthew G. Vander Heiden,et al. Understanding the Intersections between Metabolism and Cancer Biology , 2017, Cell.
[175] Xavier Golay,et al. Amide proton transfer imaging of human brain tumors at 3T , 2006, Magnetic resonance in medicine.
[176] K. Polyak,et al. Tumorigenesis: it takes a village , 2015, Nature Reviews Cancer.
[177] C. Thompson,et al. Akt-dependent transformation: there is more to growth than just surviving , 2005, Oncogene.
[178] T. Jang,et al. Volumetric spiral chemical shift imaging of hyperpolarized [2‐13c]pyruvate in a rat c6 glioma model , 2016, Magnetic resonance in medicine.
[179] Paul Workman,et al. Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies. , 2006, Journal of the National Cancer Institute.
[180] Pernille R. Jensen,et al. Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate , 2008, Nature.
[181] H J Halpern,et al. Oxymetry deep in tissues with low-frequency electron paramagnetic resonance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[182] J. Waterton,et al. Exploring ΔR2* and ΔR1 as imaging biomarkers of tumor oxygenation , 2013, Journal of magnetic resonance imaging : JMRI.
[183] C. James,et al. Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging , 2011, Journal of magnetic resonance imaging : JMRI.
[184] John Kurhanewicz,et al. Application of Good's buffers to pH imaging using hyperpolarized (13)C MRI. , 2015, Chemical communications.
[185] Richard L Ehman,et al. MR elastography derived shear stiffness—a new imaging biomarker for the assessment of early tumor response to chemotherapy , 2014, Magnetic resonance in medicine.
[186] H. Shinmoto,et al. Diffusion kurtosis imaging study of prostate cancer: Preliminary findings , 2014, Journal of magnetic resonance imaging : JMRI.
[187] Chunlei Liu. Susceptibility tensor imaging , 2010, Magnetic resonance in medicine.
[188] Siqing Shan,et al. The pervasive presence of fluctuating oxygenation in tumors. , 2008, Cancer research.
[189] T. Jang,et al. Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized (13)C magnetic resonance spectroscopic imaging. , 2013, Neuro-oncology.
[190] Kristen Scott,et al. Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma , 2012, NeuroImage.
[191] G. Tamma,et al. Oxidative Medicine and Cellular Longevity , 2017 .
[192] Aaron M. Coffey,et al. 15N Hyperpolarization of Imidazole-15N2 for Magnetic Resonance pH Sensing via SABRE-SHEATH , 2016, ACS sensors.
[193] L. D. McPhail,et al. Intrinsic susceptibility MR imaging of chemically induced rat mammary tumors: relationship to histologic assessment of hypoxia and fibrosis. , 2010, Radiology.
[194] B. Rosen,et al. Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.